Overview

Brief Intervention for OCD Fears

Status:
Suspended

Trial end date:
2022-06-01

Target enrollment:

Participant gender:

Summary

The study will test the efficacy of propranolol or placebo, administered after reactivation of a previously acquired obsessive-compulsive disorder (OCD) fear, in reducing fear and avoidance in OCD.

Phase:

Phase 4

Details

Lead Sponsor:

New York State Psychiatric Institute

Treatments:

Propranolol